Valerie Israel, DO, Oncology, Bullhead City, AZ, Southern Arizona Veterans Affairs Health Care System

ValeriePrattIsraelDO

Oncology Bullhead City, AZ

Hematologic Oncology

Hematology/Medical Oncology

Dr. Israel is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Israel's full profile

Already have an account?

  • Office

    Southwest Oncology Centers
    2755 Silver Creek Rd
    Bullhead City, AZ 86442
    Phone(928) 514-2222
    Fax(928) 514-2221
  • Is this information wrong?

Education & Training

  • University of Southern California - LAC+USC Medical Center
    University of Southern California - LAC+USC Medical CenterFellowship, Hematology/Oncology, 1992 - 1995
  • College of Osteopathic Medicine of the Pacific
    College of Osteopathic Medicine of the PacificClass of 1989
  • California State University, Los AngelesM.S., Psychology & Biology, 1982
  • University of California, IrvineB.S., Biological Sciences, 1979

Certifications & Licensure

  • AZ State Medical License
    AZ State License 2013 - 2022
  • CA State Medical License
    CA State License 1990 - 2019
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III nonsmall-cell lung can...  
    Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J, J Clin Oncol, 1/15/2001
  • Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial  
    Lara PN Jr, Gandara DR, Longmate J, Gumerlock PH, Lau DH, Edelman MJ, Gandour-Edwards R, Mack PC, Israel V, Raschko J, Frankel P, Perez EA, Lenz HJ, Doroshow JH, Cancer Chemother Pharmacol, 1/1/2001
  • Phase I/II trial of irinotecan, carboplatin, and paclitaxel in advanced or metastatic NSCLC  
    Natale RB, Socinski M, Sandler A, Israel VP, Miller L, Oncology, 1/1/2000
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Phase I study of biweekly paclitaxel and carboplatin plus GCSF
    Israel V, Garcia AA, , Russell CA, Dimery I, Rogers M, Angeles A, Kutsch K, Jeffers S, Muggia FM, PASCO, 1/1/1999
  • Phase I study of doxil (liposomal doxorubicin) in combination with paclitaxel
    Israel VK, Jeffers S, Bernal G, Rueda G, Roman L, Roma CP, Rosales R, Amantea M, and Muggia FM, PASCO, 1/1/1998
  • Liposomal doxorubicin (doxil): Prospects for its integration into treatment of solid tumors
    Muggia FM, Israel V, Formenti S, Garcia A, Safra T, Jeffers S, Kempf R, PASCO, 1/1/1997
  • Join now to see all

Hospital Affiliations